FAQs & Fact Sheets: Monoclonal Antibodies
Emergency Use Authorizations [EUA]:
FAQs (Survivor Corps): Monoclonal Antibodies
FDA Update: (Apr. 16, 2021) - FDA Revokes EUA for Monoclonal Antibody Bamlanivimab
Casirivimab & Imdevimab (Regeneron):
FAQs from the FDA: EUA for Casirivimab and Imdevimab
Bamlanivimab & Etesevimab (Eli Lilly):
FAQs from the FDA: EUA for Bamlanivimab and Etesevimab